The role of proteasome inhibitors in solid tumors

Annals of Medicine
David J Park, Heinz-Josef Lenz

Abstract

The proteasome is a multicatalytic protein complex whose principal task is the degradation of a large array of proteins within the cell. Its substrates include proteins involved in cell cycle regulation, tumor suppression, apoptosis, transcription, and angiogenesis, among others. This makes the inhibition of the proteasome a promising novel therapeutic approach to cancer treatment. Bortezomib (Velcade) is the first proteasome inhibitor to have shown anti-cancer activity and reached clinical trials. Preclinical and early clinical trials in both solid tumors and hematological malignancies demonstrate that bortezomib is a relatively well-tolerated and active agent, either alone or in combination with traditional chemotherapeutic drugs. Clinical trials that may help delineate the role of bortezomib in the treatment solid tumors either as single agent or in combination are ongoing.

Citations

Sep 1, 2007·Alcoholism, Clinical and Experimental Research·Terrence M DonohueNatalia A Osna
Mar 11, 2005·Expert Review of Anti-infective Therapy·Patricia P Klinger, Ulrich Schubert
Nov 1, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael P FanucchiJoan H Schiller
Nov 1, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Melanie B Thomas, James L Abbruzzese
Oct 26, 2005·Breast Cancer Research and Treatment·Gert G Van den EyndenKenneth L van Golen
Aug 4, 2007·The Oncologist·Giovanni Luca CeresoliArmando Santoro
Nov 10, 2005·The Journal of Biological Chemistry·Yolanda FernándezMaría S Soengas
Jul 19, 2005·Cancer Research·Jian-Zhong QinBrian J Nickoloff
Mar 1, 2005·Photodiagnosis and Photodynamic Therapy·Ana P CastanoMichael R Hamblin
Dec 3, 2014·Redox Biology·Terrence M Donohue, Paul G Thomes

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Related Papers

Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progrès Dans Les Recherches Sur Le Cancer
I ZavrskiO Sezer
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Peter M VoorheesRobert Z Orlowski
© 2022 Meta ULC. All rights reserved